4WEB Medical surpassed a 100,000 spine procedure milestone using its proprietary TRUSS implant technology. 4WEB was the first company to achieve FDA 510(k) clearance for a spine implant manufactured with 3D printing technology.
The company has ongoing clinical studies investigating how its truss implant design delivers therapeutic strain to a surgical site when under normal physiologic loading conditions.
“Achieving this volume of surgical procedures worldwide is significant,” said 4WEB President Brad Niemann. “It speaks directly to the vision of the company and the years of dedication providing a unique, differentiated interbody technology. I’d like to thank the surgeon community. This milestone is only achieved through your ongoing commitment to our TRUSS implant technology.”
Mr. Niemann further commented, “We are well positioned and accelerating our investments in the company’s core technology while providing differentiated solutions. We believe we are entering our next phase of significant growth at 4WEB. I’d like to thank our team members worldwide; we are excited about our future.”
4WEB Medical surpassed a 100,000 spine procedure milestone using its proprietary TRUSS implant technology. 4WEB was the first company to achieve FDA 510(k) clearance for a spine implant manufactured with 3D printing technology.
The company has ongoing clinical studies investigating how its truss implant design delivers therapeutic strain to a...
4WEB Medical surpassed a 100,000 spine procedure milestone using its proprietary TRUSS implant technology. 4WEB was the first company to achieve FDA 510(k) clearance for a spine implant manufactured with 3D printing technology.
The company has ongoing clinical studies investigating how its truss implant design delivers therapeutic strain to a surgical site when under normal physiologic loading conditions.
“Achieving this volume of surgical procedures worldwide is significant,” said 4WEB President Brad Niemann. “It speaks directly to the vision of the company and the years of dedication providing a unique, differentiated interbody technology. I’d like to thank the surgeon community. This milestone is only achieved through your ongoing commitment to our TRUSS implant technology.”
Mr. Niemann further commented, “We are well positioned and accelerating our investments in the company’s core technology while providing differentiated solutions. We believe we are entering our next phase of significant growth at 4WEB. I’d like to thank our team members worldwide; we are excited about our future.”
Copy to clipboard 
